These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36185786)

  • 1. Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C.
    Ichikawa T; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Miyazaki O; Kuribayashi Y; Ikeda T; Okamura T; Nakao K
    Biomed Rep; 2022 Nov; 17(5):84. PubMed ID: 36185786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study.
    Xu Y; Shen L; Liu L; Zhang Z; Hu W
    Front Endocrinol (Lausanne); 2022; 13():843912. PubMed ID: 35898467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Therapy with Vitamin K
    Kuwabara A; Nagae A; Kitagawa M; Tozawa K; Kumode M; Tanaka K
    J Nutr Sci Vitaminol (Tokyo); 2020; 66(3):278-284. PubMed ID: 32612091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis.
    Nagata Y; Inaba M; Imanishi Y; Okazaki H; Yamada S; Mori K; Shoji S; Koyama H; Okuno S
    Osteoporos Int; 2015 Mar; 26(3):1053-61. PubMed ID: 25403902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamins K and D deficiency in severe motor and intellectually disabled patients.
    Sakai T; Shirai T; Oishi T
    Brain Dev; 2021 Feb; 43(2):200-207. PubMed ID: 33139126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid effects on bone strength in children with renal diseases.
    Aoyagi J; Kanai T; Ito T; Odaka J; Saito T; Betsui H; Kurosaki M; Maru T; Yamagata T
    Nephrology (Carlton); 2021 Feb; 26(2):119-125. PubMed ID: 33207023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIVKA‑II is associated with liver function, bone metabolism, and muscle function in patients with liver disease.
    Honda T; Ichikawa T; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Miyazaki O; Kuribayashi Y; Ikeda T; Okamura T; Nagata K; Nakao K
    Biomed Rep; 2024 Jan; 20(1):2. PubMed ID: 38222867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of vitamin K-rich green leafy vegetables on bone metabolism: A 4-week randomised controlled trial in middle-aged and older individuals.
    Sim M; Lewis JR; Prince RL; Levinger I; Brennan-Speranza TC; Palmer C; Bondonno CP; Bondonno NP; Devine A; Ward NC; Byrnes E; Schultz CJ; Woodman R; Croft K; Hodgson JM; Blekkenhorst LC
    Bone Rep; 2020 Jun; 12():100274. PubMed ID: 32455149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Mass Index Is Positively Associated With Bone Mineral Density in Hemodialysis Patients.
    Ito K; Ookawara S; Hibino Y; Imai S; Fueki M; Bandai Y; Yasuda M; Kamimura T; Kakuda H; Kiryu S; Wada N; Hamashima Y; Kobayashi T; Shindo M; Sanayama H; Ohnishi Y; Tabei K; Morishita Y
    Front Med (Lausanne); 2020; 7():187. PubMed ID: 32478086
    [No Abstract]   [Full Text] [Related]  

  • 11. A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients.
    Horai T; Hishimoto A; Otsuka I; So T; Mouri K; Shimmyo N; Boku S; Okishio N; Sora I
    Neuropsychiatr Dis Treat; 2018; 14():663-669. PubMed ID: 29535522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide.
    Okamura T; Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Miyazaki O; Kuribayashi Y; Ikeda T; Taura N; Nakao K
    Biomed Rep; 2022 Jan; 16(1):6. PubMed ID: 34900255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women.
    Kim SM; Kim KM; Kim BT; Joo NS; Kim KN; Lee DJ
    J Korean Med Sci; 2010 Aug; 25(8):1171-5. PubMed ID: 20676328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends of bone mineral density and bone quality in a paediatric kidney transplant recipient: A case report.
    Aoyagi J; Kanai T; Ito T; Saito T; Betsui H; Kurosaki M; Maru T; Ono M; Tajima T
    Nephrology (Carlton); 2024 Sep; ():. PubMed ID: 39315463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of serum undercarboxylated osteocalcin correlates with bone quality assessed by calcaneal quantitative ultrasound sonometry in young Japanese females.
    Suzuki Y; Maruyama-Nagao A; Sakuraba K; Kawai S
    Exp Ther Med; 2017 May; 13(5):1937-1943. PubMed ID: 28565790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Affect of Lifestyle on Bone Mineral Density and Bone Turnover in Young Women.
    Motooka N; Matsuo H
    Kobe J Med Sci; 2020 Feb; 65(4):E124-E131. PubMed ID: 32201427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
    Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women.
    Szulc P; Arlot M; Chapuy MC; Duboeuf F; Meunier PJ; Delmas PD
    J Bone Miner Res; 1994 Oct; 9(10):1591-5. PubMed ID: 7817805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.
    Atalay S; Elci A; Kayadibi H; Onder CB; Aka N
    Ann Lab Med; 2012 Jan; 32(1):23-30. PubMed ID: 22259775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.